Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises HealthCap in conjunction with its investment in Elsa Science
Mandate

Vinge advises HealthCap in conjunction with its investment in Elsa Science

November 05, 2021 M&A

Vinge has advised HealthCap in conjunction with its investment in Elsa Science, which develops an app that provides patients suffering from rheumatoid arthritis to receive tailormade treatment.

The financing round is headed by Healthcap and also existing investors such as the Finnish venture capital company Inventure, Crowberry Capital from Iceland, Norrsken VC as well as Noaber from the Netherlands.

Vinge’s team primarily consisted of Johan Winnerblad, Stina Bengtsson, Hannah Kajlinger and Lisa Hörnqvist.

Related

Vinge has advised Fidelio Capital AB in connection with its acquisition of Avy AB

 Vinge has advised Fidelio Capital AB in connection with the company's acquisition of Avy AB, a leading Nordic technology company within digital services for the real estate industry.
January 28, 2026

Vinge advises Sveafastigheter on the establishment of its EMTN programme and issuance of EUR 300 million bonds

 Vinge has advised Sveafastigheter AB (publ) as Swedish legal counsel on the establishment of a euro medium-term note programme (the “EMTN programme”) with a framework of EUR 2 billion and the issuance of senior unsecured bonds totalling EUR 300 million under the EMTN programme.
January 23, 2026

Vinge advises EQT AB on its combination with Coller Capital

 Vinge advises EQT AB on its acquisition Coller Capital, a global secondaries firm with nearly USD 50 billion in total assets under management across institutional, private wealth and insurance-related capital.
January 22, 2026